Stocks · News reference
Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. futures mixed; Syndax plunged 17% after its lung fibrosis trial missed its endpoint. Zhibao, Chaince, Six Flags and tech stocks also fell premarket.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
$7 Billion Gone: DRAM ETF Investors Crushed As Memory Chip Mania Unravels
DRAM ETF investors face $7 billion in estimated losses as a 40% plunge rattles the artificial intelligence memory chip trade.
'TSMC Weighs Making Advanced Memory Chips to Capture More AI Spending' - The Information
SK Hynix Shares Decline Amid Broader Semiconductor Market Sell-Off
SK Hynix shares experienced a significant decline as part of a broader technology sector sell-off triggered by concerns over artificial intelligence infrastructure spending.
Micron Technology vs. Western Digital: Which Tech Stock Is the Better Buy for 2027?
Both Micron Technology and Western Digital are benefiting from AI-driven demand for memory and storage, but Western Digital is recommended as the better buy for 2027 due to greater resilience during market downturns. While Micron shows explosive growth with 256% revenue increase, its gross margins are highly volatile (ranging from -9% to 81%), making it vulnerable to memory price fluctuations. Western Digital's more stable gross margins (22% to 49%) and consistent storage demand provide better downside protection.
Six Flags: 3 Key Takeaways for Long-Term Investors
Six Flags outlined its post-merger strategic priorities focused on expanding profit margins and reducing debt. The company is optimizing its portfolio by selling noncore assets, leveraging regional pass networks to drive cross-park visitation (up 5x year-over-year), and implementing strict capital allocation discipline. Free cash flow improved by $300 million in the first nine months, with management targeting 4x net debt leverage. Despite temporary October headwinds from weather and ride closures, underlying demand remains steady.